Drug Trial Radar · NCT01629563
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
Last checked: Nov 20, 2026Latest source record: Sep 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
451
Actual
Start
Jun 2012
Primary completion
Jan 2015
Study completion Jan 2015
Sponsor
- Lead sponsor
- PregLem SAIndustry
- Sponsor type
- Industry
- First posted
- Jun 27, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase III, multicentre, randomized, double-blind, parallel group, long-term study investigating the efficacy and safety of the 5mg and 10mg doses of PGL4001 for the treatment of uterine myoma.
Conditions
- Uterine Fibroids
Interventions
PGL4001 5 mgDrug
PGL4001 5 mg daily administration
PGL4001 10 mgDrug
PGL4001 10mg daily administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Who Are in Amenorrhea at the End of All Four Treatment CoursesTime frame: 18 months study duration per subject (4 3-month intermittent treatment courses)
Locations
49 sites in 11 countries. Site status is shown where the registry gives one.
Cliniques Universitaires Saint-Luc Gynécologie-Obstétrique
Brussels, Belgium
UZ Leuven Campus Gasthuisberg
Leuven, Belgium
CHU de Liège, CHR de la Citadelle Gynécologie-Obstétrique
Liège, Belgium
CHU Mont-Godinne
Yvoir, Belgium
Centrum ambulantni gynekologie a primarni pece
Brno, Czechia
FN Brno Gynekologicko - porodnická klinika
Brno, Czechia
Sanatorium SANUS
Hradec Králové, Czechia
Nemocnice Jihlava Gynekologicko - porodnicke oddeleni
Jihlava, Czechia
G-CENTRUM Olomouc s.r.o.
Olomouc, Czechia
FN Olomouc, Porodnicko-Gynekologicka klinika
Olomouc, Czechia
Femina Sana, s.r.o.
Prague, Czechia
Hôpital Bicêtre - APHP
Le Kremlin-Bicêtre, France
Hôpital Bichat, Service de Gynécologie Obstétrique
Paris, France
CHU Bretonneau Service de Gynécologie Obstétrique
Tours, France
Private practice
Hamburg, Germany
Private practice
Hamburg, Germany
Medizinische Hochschule Hannover Klinik für Frauenheilkunde und Geburtshilfe
Hanover, Germany
Frauenarztpraxis
Hessen, Germany
Praxis für Frauenheilkunde, Klinische Forschung und Weiterbildung
Magdeburg, Germany
Technische Universität München
München, Germany
Rethy Pal Korhaz és Rendelointezet Szuleszeti es Nogyogyaszati Osztaly
Békéscsaba, Hungary
Institution Robert Karoly Maganklinika
Budapest, Hungary
Szent Anna Szuleszeti, Nogyogyaszati es Ultrahang Maganrendelo
Debrecen, Hungary
Josa Andras Oktatokorhaz
Nyíregyháza, Hungary
Fejer Megyei Szent Gyorgy Korhaz Szuleszeti es Nogyogyaszati Osztaly
Székesfehérvár, Hungary
Szuleszeti es Nogyogyaszati Osztaly
Szentes, Hungary
Sandor Dent Bt.
Szolnok, Hungary
Dipartimento di Ostetricia e Ginecologia, Università degli Studi di Catanzaro "Magna Graecia"
Catanzaro, Italy
Policlinico Universitario "Agostino Gemelli"
Roma, Italy
Riga 1. hospital
Riga, Latvia
Latvian Medical Marine Center
Riga, Latvia
Medical Company "ARS"
Riga, Latvia
Saules Family Medicine Center
Kaunas, Lithuania
Family Medicine Centre"Seimos Gydytojas"
Vilnius, Lithuania
Private Clinic "Maxmeda"
Vilnius, Lithuania
Private Clinic "Kardiolita"
Vilnius, Lithuania
Centrul Medical SANA SRL
Bucharest, Romania
Quantum Medical Center SRL Obstetrica-Ginecologie
Bucharest, Romania
Fortis Medical Center SRL Obstetrica Ginecologie
Bucharest, Romania
Spitalul Clinic Dr. I.Cantacuzino sectia Obstetrica-Ginecologie
Bucharest, Romania
Showing 40 of 49 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.